Cocaine Use Disorders and Serum Magnesium Profile

被引:1
|
作者
Tonioni, F. [1 ]
Martinotti, G. [1 ]
Barra, A. [1 ]
Martinelli, D. [1 ]
Autullo, G. [1 ]
Rinaldi, C. [1 ]
Tedeschi, D. [1 ]
Janiri, L. [1 ]
Bria, P. [1 ]
机构
[1] Catholic Univ, Sch Med, Dept Psychiat, Rome, Italy
关键词
Magnesium; Cocaine; Psychopathology; Craving; STRUCTURED CLINICAL INTERVIEW; MAJOR DEPRESSED-PATIENTS; ASPARTATE HYDROCHLORIDE; ERYTHROCYTE MAGNESIUM; CALCIUM; SYMPTOMS; PLASMA; PATHOPHYSIOLOGY; SCHIZOPHRENIA; PREFERENCE;
D O I
10.1159/000218078
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: Magnesium influences the nervous system via its actions on the release and metabolism of neurotransmitters, and abnormal magnesium metabolism has been implicated in several neuropsychiatric disorders with prominent mood symptoms. The aim of this study was to compare the serum levels of magnesium of cocaine addicts to those of heroin addicts and normal controls. We also attempted to clarify the relationship between the pathophysiology of cocaine abuse and magnesium levels by investigating their association with various clinical dimensions. Methods: Eighty-five consecutive subjects with a history of cocaine or opiate use disorders were recruited, evaluated and compared with 100 controls. The cocaine and heroin abusers were assessed with a 10-cm Visual Analogue Scale, the Symptom Check List-90 Revised, the Brown-Goodwin Scale, and the Barrat Impulsiveness Scale. Results: Magnesium levels were higher in the cocaine group compared to the opiate group and control. Male subjects had lower magnesium levels than the females of all three groups. Scores of impulsiveness, aggressiveness, craving and psychiatric symptomatology were not significantly different between the opiate and cocaine addicts. Discussion: This is the first study evaluating the magnesium level in cocaine addicts. Cocaine addicts showed higher total plasma magnesium levels than opiate addicts and normal controls, even though they remained in the normal range. The roles of the psychiatric comorbidity, of a pharmacokinetic association and of a pharmacodynamic interaction are discussed. Further prospective studies comparing serum levels of cocaine at different times are needed. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:159 / 164
页数:6
相关论文
共 50 条
  • [11] Molecular genetics of cocaine use disorders in humans
    Noèlia Fernàndez-Castillo
    Judit Cabana-Domínguez
    Roser Corominas
    Bru Cormand
    Molecular Psychiatry, 2022, 27 : 624 - 639
  • [12] Molecular genetics of cocaine use disorders in humans
    Fernandez-Castillo, Noelia
    Cabana-Dominguez, Judit
    Corominas, Roser
    Cormand, Bru
    MOLECULAR PSYCHIATRY, 2022, 27 (01) : 624 - 639
  • [13] BDNF as a therapeutic candidate for cocaine use disorders
    McGinty, Jacqueline F.
    ADDICTION NEUROSCIENCE, 2022, 2
  • [14] Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav(R) in Sleep Disorders: A Profile of Its Use
    Heo, Young-A
    CNS DRUGS, 2022, 36 (05) : 541 - 549
  • [15] Disorders of the synostosis and the changes in the concentration of magnesium in the serum
    Golec, E
    Kopanski, Z
    Schlegel-Zawadzka, M
    Sibiga, W
    Sadlik, K
    MACROELEMENTS AND TRACE ELEMENTS, 1999, : 639 - 643
  • [16] Correction to: Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav®) in Sleep Disorders: A Profile of Its Use
    Young-A Heo
    CNS Drugs, 2022, 36 : 551 - 551
  • [17] SERUM IONIZED MAGNESIUM LEVELS IN INFANTS EXPOSED TO COCAINE IN-UTERO
    MARCUS, JC
    VALENCIA, G
    ALTURA, BT
    JEANBAPTISTE, D
    SINHA, K
    ALTURA, BM
    ANNALS OF NEUROLOGY, 1994, 36 (03) : 529 - 529
  • [18] SERUM MAGNESIUM LEVELS AFTER REPETITIVE MAGNESIUM CATHARTIC USE
    WOODARD, J
    SHANNON, MW
    LACOUTURE, P
    WOOLF, A
    VETERINARY AND HUMAN TOXICOLOGY, 1988, 30 (04) : 354 - 354
  • [19] Medications to treat cocaine use disorders: current options
    Buchholz, Jonathan
    Saxon, Andrew J.
    CURRENT OPINION IN PSYCHIATRY, 2019, 32 (04) : 275 - 281
  • [20] Drug fluency: A potential marker for cocaine use disorders
    Goldstein, R. Z.
    Woicik, P. A.
    Lukasik, T.
    Maloney, T.
    Volkow, N. D.
    DRUG AND ALCOHOL DEPENDENCE, 2007, 89 (01) : 97 - 101